15h
Zacks.com on MSNZacks Initiates Coverage of bioAffinity With Neutral RecommendationZacks Investment Research has recently initiated coverage of bioAffinity Technologies, Inc. BIAF, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed ...
Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But how do you find the right combination of stocks?
Today's Research Daily features the Q4 earnings season scorecard and updated analyst reports on 16 major stocks, including Meta Platforms, Mastercard and Adobe, as well as two micro-cap stocks ...
Fortune Brands Innovations expects full-year earnings in the range of $4.15 to $4.45 per share. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks ...
Equities research analysts at Zacks Small Cap cut their FY2025 earnings per share estimates for shares of Protalix BioTherapeutics in a report released on Monday, February 3rd. Zacks Small Cap analyst ...
Chicago, IL – January 27, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec.
Zacks Small-Cap Core Fund earns an Average Process Pillar rating. The most significant contributor to the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over ...
14h
Zacks.com on MSNAll You Need to Know About South Atlantic Bancshares (SABK) Rating Upgrade to Strong BuySouth Atlantic Bancshares, Inc. (SABK) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results